Diagnosis and Management of Polymyalgia Rheumatica/Giant Cell Arteritis

被引:0
|
作者
Carlo Salvarani
Luigi Macchioni
Ignazio Olivieri
Fabrizio Cantini
Luigi Boiardi
机构
[1] Azienda Ospedaliera Arcispedale S. Maria Nuova,Servizio di Reumatologia
[2] Ospedale S. Orsola-Malpighi,Unità Reumatologica
[3] Ospedale di Prato,Unità Reumatologica
[4] Arcispedale S. Maria Nuova,Unità Reumatologica
来源
BioDrugs | 1998年 / 9卷
关键词
Adis International Limited; Rheumatol; Giant Cell Arteritis; Temporal Artery; Pelvic Girdle;
D O I
暂无
中图分类号
学科分类号
摘要
There are no standardised diagnostic criteria for polymyalgia rheumatica. The combination of persistent pain (at least 1 month) with marked morning stiffness in at least 2 of the neck, shoulder or pelvic girdle is characteristic of polymyalgia rheumatica. The other criteria are age >50 years, erythrocyte sedimentation rate (ESR) >40 mm/hour, rapid response to corticosteroids and an absence of other diseases capable of causing the musculoskeletal symptoms. A normal ESR does not exclude a diagnosis of polymyalgia rheumatica. Diagnostic temporal artery biopsy is recommended in all patients suspected of having giant cell arteritis. The segment of temporal artery with abnormality on physical examination should be biopsied.
引用
收藏
页码:25 / 32
页数:7
相关论文
共 50 条
  • [1] Diagnosis and management of polymyalgia rheumatica giant cell arteritis
    Salvarani, C
    Macchioni, L
    Olivieri, I
    Cantini, F
    Boiardi, L
    BIODRUGS, 1998, 9 (01) : 25 - 32
  • [2] Polymyalgia rheumatica and giant cell arteritis: diagnosis and management
    Sun, Margaret Man-Ger
    Pope, Janet E.
    CURRENT OPINION IN RHEUMATOLOGY, 2025, 37 (01) : 32 - 38
  • [3] Management of giant cell arteritis and polymyalgia rheumatica
    Meskimen, S
    Cook, TD
    Blake, RL
    AMERICAN FAMILY PHYSICIAN, 2000, 61 (07) : 2061 - 2068
  • [4] Differential Diagnosis of Polymyalgia Rheumatica and Giant Cell Arteritis
    Keysser, G.
    AKTUELLE RHEUMATOLOGIE, 2014, 39 (04) : 227 - 231
  • [5] Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis
    Matteson, Eric L.
    Buttgereit, Frank
    Dejaco, Christian
    Dasgupta, Bhaskar
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2016, 42 (01) : 75 - +
  • [6] Giant cell arteritis and polymyalgia rheumatica - Pathophysiology and management
    Gonzalez-Gay, Miguel A.
    Garcia-Porrua, Carlos
    Miranda-Filloy, Jose A.
    Martin, Javier
    DRUGS & AGING, 2006, 23 (08) : 627 - 649
  • [7] Optimal management of giant cell arteritis and polymyalgia rheumatica
    Charlton, Rodger
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2012, 8 : 173 - 179
  • [8] Recognition and Management of Polymyalgia Rheumatica and Giant Cell Arteritis
    Caylor, Tonya L.
    Perkins, Allen
    AMERICAN FAMILY PHYSICIAN, 2013, 88 (10) : 676 - 684
  • [9] Polymyalgia Rheumatica and Giant Cell Arteritis in Older Patients Diagnosis and Pharmacological Management
    Schmidt, Jean
    Warrington, Kenneth J.
    DRUGS & AGING, 2011, 28 (08) : 651 - 666
  • [10] Giant cell arteritis and polymyalgia rheumatica
    Marin Gonzalez, G.
    MAYO CLINIC PROCEEDINGS, 2007, 82 (01) : 133 - 133